Published in Arch Otolaryngol Head Neck Surg on May 01, 2002
Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res (2009) 1.17
Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol (2005) 1.07
The cadherin-catenin complex in nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol (2011) 0.85
Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. J Exp Clin Cancer Res (2014) 0.85
The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis. Virchows Arch (2015) 0.83
The cadherin-catenin complex in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol (2011) 0.81
Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease. J Exp Ther Oncol (2010) 0.80
p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol (2003) 0.80
Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg (2013) 0.80
Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I. J Oral Maxillofac Res (2010) 0.78
Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma. BMC Oral Health (2015) 0.75
Impairment of mesenchymal stem cells derived from oral leukoplakia. Int J Clin Exp Pathol (2015) 0.75
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
The essence of senescence. Genes Dev (2010) 8.21
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol (2009) 3.64
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell (2003) 3.31
Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol (2002) 2.11
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev (2012) 2.06
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer. Clin Cancer Res (2009) 2.03
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet (2002) 2.00
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res (2002) 1.95
Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.88
Oral malignant melanoma: a review of the literature. Oral Oncol (2006) 1.70
State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol (2010) 1.68
Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J Thorac Cardiovasc Surg (2007) 1.42
Chronic and adjustable pulmonary artery banding. J Thorac Cardiovasc Surg (2003) 1.42
Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum Mutat (2008) 1.35
NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol (2009) 1.33
SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clin Cancer Res (2011) 1.22
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. J Nucl Med (2007) 1.20
Incidence and treatment of tracheal cancer: a nationwide study in the Netherlands. Ann Surg Oncol (2006) 1.19
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology (2007) 1.18
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS One (2008) 1.14
Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol (2003) 1.11
ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 1.10
HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol (2010) 1.07
Long-term effects of carotid sinus denervation on arterial blood pressure in humans. Circulation (2002) 1.06
Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Plast Reconstr Surg (2005) 1.06
Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2002) 1.03
Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1. J Pathol (2005) 1.03
Endoscopic carbon dioxide laser diverticulostomy versus endoscopic staple-assisted diverticulostomy to treat Zenker's diverticulum. Head Neck (2011) 1.03
Baroreflex and chemoreflex function after bilateral carotid body tumor resection. J Hypertens (2003) 1.02
Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck (2007) 1.02
Targeting BRAFV600E in an inducible murine model of melanoma. Am J Pathol (2012) 1.01
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women. J Med Genet (2011) 1.01
Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res (2005) 1.01
Percutaneous tracheostomy with the guide wire dilating forceps technique: presentation of 171 consecutive patients. Head Neck (2002) 1.00
Melanocytic nevi of the oral mucosa - no evidence of increased risk for oral malignant melanoma: an analysis of 119 cases. Oral Oncol (2007) 1.00
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma. Clin Cancer Res (2003) 0.99
Oral malignant melanoma: the amsterdam experience. J Oral Maxillofac Surg (2007) 0.99
Partial matrix excision or segmental phenolization for ingrowing toenails. Arch Surg (2002) 0.99
Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer (2013) 0.98
Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. J Neuropsychiatry Clin Neurosci (2003) 0.97
Quality of integrated care for patients with head and neck cancer: Development and measurement of clinical indicators. Head Neck (2007) 0.96
Baroreflex control of muscle sympathetic nerve activity after carotid body tumor resection. Hypertension (2003) 0.95
Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma. Clin Cancer Res (2002) 0.95
Surgery for recurrent laryngeal carcinoma after radiotherapy: partial laryngectomy or total laryngectomy for a better quality of life? Otolaryngol Head Neck Surg (2005) 0.94
Early and long-term morbidity after total laryngopharyngectomy. Eur Arch Otorhinolaryngol (2010) 0.93
High complication risk of salvage surgery after chemoradiation failures. Acta Otolaryngol (2011) 0.93
Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Int J Cancer (2004) 0.92
Arterial baroreflex and peripheral chemoreflex function after radiotherapy for laryngeal or pharyngeal cancer. Int J Radiat Oncol Biol Phys (2002) 0.92
Nurse-patient communication in follow-up consultations after head and neck cancer treatment. Cancer Nurs (2014) 0.91
Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care. Cancer (2007) 0.91
DFNA2/KCNQ4 and its manifestations. Adv Otorhinolaryngol (2002) 0.90
Impact of an integrated care program for patients with head and neck cancer on the quality of care. Head Neck (2009) 0.89
Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Eur J Cancer (2009) 0.89
HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion (2003) 0.89
Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer (2003) 0.89
Clinical aspects and treatment of primary tracheal malignancies. Acta Otolaryngol (2010) 0.88
Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer (2004) 0.88
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Oral Oncol (2007) 0.88
Oral malignant melanoma associated with pseudoepitheliomatous hyperplasia. Report of a case. J Cutan Pathol (2006) 0.88
Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease. Mod Pathol (2008) 0.87
Undertreatment of tracheal carcinoma: multidisciplinary audit of epidemiologic data. Ann Surg Oncol (2008) 0.87
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol (2006) 0.87
External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up. Int J Radiat Oncol Biol Phys (2010) 0.87
Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg (2003) 0.87
Endoscopic myotomy of the cricopharyngeal muscle with CO2 laser surgery. Head Neck (2005) 0.87
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. Int J Radiat Oncol Biol Phys (2012) 0.86
Hypopharyngeal reconstruction with an anterolateral thigh flap after laryngopharyngeal resection: results of a retrospective study on 20 patients. J Plast Reconstr Aesthet Surg (2009) 0.86
Allergic colitis presenting within the first hours of premature life. Acta Paediatr (2005) 0.85
Oncogene-induced cellular senescence. Adv Anat Pathol (2010) 0.85
FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope (2006) 0.85
A multicenter, prospective, clinical trial evaluating a novel adhesive baseplate (Provox StabiliBase) for peristomal attachment of postlaryngectomy pulmonary and voice rehabilitation devices. Laryngoscope (2012) 0.84
Nurse-led follow-up care for head and neck cancer patients: a quasi-experimental prospective trial. Support Care Cancer (2012) 0.84
Oral squamous cell carcinoma and a clinically negative neck: the value of follow-up. Head Neck (2010) 0.83
The natural history of carcinoma in situ involving bronchial resection margins. Chest (2005) 0.83
Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope (2002) 0.83
Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase. Cell Biochem Biophys (2006) 0.83
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther (2011) 0.83
Histological assessment of titanium and polypropylene fiber mesh implantation with and without fibrin tissue glue. J Biomed Mater Res A (2007) 0.83
The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium. Am J Respir Crit Care Med (2007) 0.82
Anterolateral thigh flap reconstruction of large external facial skin defects: a follow-up study on functional and aesthetic recipient- and donor-site outcome. Plast Reconstr Surg (2005) 0.82
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. J Nucl Med (2003) 0.82
Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas. Radiother Oncol (2005) 0.82
Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: definition of a high-risk group and estimation of the lead time. Head Neck (2007) 0.82
Clinical use of a neck brace to improve hands-free speech in laryngectomized patients. Laryngoscope (2012) 0.81
Proliferation in Adrenocortical Tumors: Correlation with Clinical Outcome and p53 Status. Endocr Pathol (1997) 0.81
An external neck brace to support the peristomal fixation of an automatic stoma valve (ASV): 3D stereophotogrammetrical assessment. Acta Otolaryngol (2010) 0.81
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma. Head Neck (2007) 0.81
Nevus versus melanoma: to FISH, or not to FISH. Adv Anat Pathol (2011) 0.80
Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas. Eur Arch Otorhinolaryngol (2006) 0.80
Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours. J Pathol (2002) 0.80
Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance. Int J Radiat Oncol Biol Phys (2012) 0.79
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. J Am Acad Dermatol (2011) 0.79
Development and (pre-) clinical assessment of a novel surgical tool for primary and secondary tracheoesophageal puncture with immediate voice prosthesis insertion, the Provox Vega Puncture Set. Eur Arch Otorhinolaryngol (2012) 0.78
Comment on "Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo". J Invest Dermatol (2008) 0.78
Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis. Cancer (2007) 0.78
Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation. Cancer Epidemiol Biomarkers Prev (2013) 0.78